# BUPROPION HYDROCHLORIDE
> **ANDA206674** · Abbreviated New Drug Application (Generic) · Sponsor: INVAGEN PHARMS · Approved 2016-02-09
## Drug
- **FDA Application Number:** ANDA206674
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BUPROPION HYDROCHLORIDE
- **Generic name:** BUPROPION HYDROCHLORIDE
- **Active ingredients:** BUPROPION HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** INVAGEN PHARMS
- **Manufacturer:** Cipla USA Inc.,
- **First approval:** 2016-02-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206674)
---
*AI Analytics · CC0 1.0*